Clontech/杆状病毒滴定试剂盒/5次分析/631406

价格
¥700000.00
货号:631406
浏览量:127
品牌:Clontech
服务
全国联保
正品保证
正规发票
签订合同
商品描述

This kit provides a fast and simple method for determining titers of baculovirus stocks. The kit uses a standard immunological assay to accurately determine baculovirus titers within 48 hr, while plaque and end-point dilution assays typically require 5–10 days. In BacPAK Baculovirus expression systems, infected cells express viral antigens long before plaques are formed. The BacPAK rapid titer assay allows titer determination after a much shorter incubation period. Furthermore, the titers obtained are comparable to those obtained with other methods. This kit is suitable for use with any virus stock with a titer of more than 104 pfu/ml and is compatible with all commonly available (AcMNPV-based) baculovirus expression systems.

This kit provides a fast and simple method for determining titers of baculovirus stocks. The kit uses a standard immunological assay to accurately determine baculovirus titers within 48 hr, while plaque and end-point dilution assays typically require 5–10 days. In BacPAK Baculovirus expression systems, infected cells express viral antigens long before plaques are formed. The BacPAK rapid titer assay allows titer determination after a much shorter incubation period. Furthermore, the titers obtained are comparable to those obtained with other methods. This kit is suitable for use with any virus stock with a titer of more than 104 pfu/ml and is compatible with all commonly available (AcMNPV-based) baculovirus expression systems.

The rapid titer immunoassay uses a primary monoclonal antibody raised against an AcMNPV envelope glycoprotein (gp64) to accurately identify virus-infected cells. A secondary HRP-conjugated antibody enables you to visualize infected cells by light microscopy and determine viral titer. Recently, we have improved the protocol to consistently offer our best ever signal-to-noise ratio for identifying cells.

BacPAK qPCR Titration Kit

This kit provides an extremely fast and simple method for titrating your viral stocks. The kit uses a quick DNA purification step before determining viral genome content using qPCR and green intercalating dye technologies. This titration kit requires only 4 hours and works with any AcMNPV-based baculoviral vector. Using qPCR enables you to perform viral harvest and target cell infection on the same day. You can avoid delays that lead to reduced viral infectivity and infect target cells at a known multiplicity of infection (MOI) for more consistent results.The BacPAK qPCR Titration determines the viral genome copy number in baculoviral preparations from a calibrated DNA standard curve. The procedure is simple: viral DNA and BacPAK control DNA are serially diluted and subjected to qPCR. The DNA copy number of each viral sample is then determined by comparing its Ct value to a standard curve generated by plotting the Ct values of the diluted control samples against their respective copy numbers.With its simplicity, reproducibility, and short processing time, the BacPAK qPCR Titration Kit is ideal for determining baculoviral DNA titers. Accurate and rapid titration provides the means to producing consistent results using high-quality viral supernatants in the shortest possible time.

Why you need to know your titer:

  • Confirm the success of your packaging reaction to avoid wasting time with your experiments
  • Perform consistent experiments
  • Ensure sufficient MOIs such that 100% of your cells are transduced
  • Control copy number and hence expression levels
 More Less
美国Clontech www.clontech.com www.takara.com.cn www.takara-bio.com www.takara.co.jp 2005年7月1日,日本最大的生物工程公司TaKaRa公司据说花费了6千万美元成功此收购计划已经于2005年8月底完成,Clontech已成为TaKaRa全资子公司。美国Clontech是1984年由华人方瑞贤创立的,一度曾经是众多海外华人的骄傲。因为方瑞贤创立的是全美第一家,也是建立了最大的分子生物公司,更重要的是Clontech建立了生物技术中建立基因文库的模式。在Clontech被BD收购时已有四百名员工,包括六十五位博士,拥有五十多个专利,产品已达两千多个,堪称全球数一,数二的基因库,提供全球三十多个国家基因实验室或学术界做研究之用。该公司有曾于预期四,预期五,预期八及预期九年被圣荷西及旧金山商业报纸选为一百个成长速度的私人公司。Clontech公司一直锐意进取,其开发的产品多次获得全美R&D100金奖。产品范围包括基因识别,基因表达,基因功能研究,大家熟悉的Smart Race,Altas DNA矩阵,SSH消减杂交,MTN膜,多色荧光蛋白载体,MatchMaker酵母双杂交系列也在其中。TaKaRa公司于1979年年从生产限制性内切酶起步,首先将PCR技术引入日本市场,并逐渐成为日本生命科学研究领域领先的公司.TaKaRa在2004年财政年度试剂销售达到118亿日元(1十亿美元左右),其中85%的收益来自于日本本土市场,其他有部分来自于中国等亚洲市场。此次收购会给Takara带来以下收益:极大地丰富Takara原来的产品线;迅速扩大TaKaRa在欧美市场的份额,因为Clontech 70%以上的销售是来自于欧美,而Takara 85%的收益来自于日本本土市场。本次收购将全面扩展日本产品在欧美的销售。另外宝将整合并加强日本本土和位于美国的Clontech公司研发部,加快产品的开发,提高宝在全球生命科学研究市场的份额。